We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Pegylated interferon alfa-2a yields high rates of hematologic and molecular response in patients with advanced essential thrombocythemia and polycythemia vera.
- Authors
Quintás-Cardama, Alfonso; Kantarjian, Hagop; Manshouri, Taghi; Luthra, Rajyalakshmi; Estrov, Zeev; Pierce, Sherry; Richie, Mary Ann; Borthakur, Gautam; Konopleva, Marina; Cortes, Jorge; Verstovsek, Srdan
- Abstract
We conducted a phase II study of pegylated interferon alfa-2a (PEG-IFN-alpha-2a) in patients with essential thrombocythemia (ET) and polycythemia vera (PV).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Vol 27, Issue 32, p5418
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2009.23.6075